In the United States, federal health agencies say nearly all people have some PFAS in their blood. In Europe human biomonitoring studies have also found PFAS widely present, including in adolescents.
That sounds dramatic and it is. But it is also important to stay precise.
“Detected in blood” does not automatically mean “causing disease in this individual.” PFAS blood testing can show that exposure happened, but it cannot by itself diagnose a health problem, predict the future, or tell you exactly where the exposure came from. U.S. health agencies are very explicit about that. (1)
PFAS are sometimes called “forever chemicals” because most of them break down very slowly in the environment. Some also leave the human body slowly. According to ATSDR estimated human half-lives vary widely by compound but can stretch into years for chemicals such as PFOA, PFOS, PFHxS, and PFNA. That is one reason blood is often used in PFAS biomonitoring.
This does not mean all PFAS behave the same way. There are thousands of PFAS, and they differ significantly in persistence, mobility, and toxicology. That is also why regulators and scientists are careful not to make identical claims for the whole group. (2)
The short answer: very widespread.
In the U.S. NHANES biomonitoring has tracked PFAS in blood for years and federal agencies state that nearly all people in the country have PFAS in their blood. Some blood levels have gone down over time for certain legacy PFAS, which suggests that phase-outs and restrictions can work. But presence remains widespread.
In Europe the picture is also serious. HBM4EU reported that PFOS and PFOA still occur in the highest concentrations among the PFAS measured in European blood samples. The German Environment Agency also highlighted that PFAS were found in all adolescent blood samples examined across Europe in one major dataset, and the European Environment Agency has reported that an average of 14.3% of studied teenagers exceeded the health-based guidance value, with some countries above 20%. (3)
Graph source: https://www.eea.europa.eu/en/european-zero-pollution-dashboards/indicators/risk-of-pfas-in-humans
That does not mean every teenager with detectable PFAS will get sick. It does mean exposure is broad enough to be a public health issue rather than a niche contamination story.
The strongest mainstream position today is not “PFAS causes everything.” It is more careful than that. U.S. EPA says current research suggests that exposure to certain PFAS may lead to adverse health outcomes, while also stressing that research is still ongoing, especially for low-level long-term exposure and for the many PFAS that have been studied less thoroughly.
The U.S. National Academies went further by reviewing the evidence across health outcomes. Their 2022 guidance concluded that there is sufficient evidence of an association between PFAS exposure and decreased antibody response, dyslipidemia or elevated cholesterol, decreased infant and fetal growth and kidney cancer. They also found evidence of association for several other outcomes, though not always at the same strength. (5)
That wording matters. “Association” is not the same as guaranteed causation in every person. But let’s be clear: it is also not nothing. When multiple human studies, toxicology data and public health reviews point in the same direction, regulators start paying attention. That is exactly what has happened here. (2)
For most people this is not as straightforward as it sounds.
ATSDR says PFAS blood tests are most useful in scientific investigations or in situations with known elevated exposure. The result can show how much of certain PFAS are in your blood at the time of testing, but it does NOT tell you:
There are recommendations considering PFAS blood testing for people with a history of elevated exposure and they proposed clinical follow-up ranges for the sum of certain PFAS. But even there the message is not to panic. It is structured risk interpretation and screening, especially for people with documented exposure pathways. (6)
In other words PFAS blood testing CAN be useful, BUT only for certain people and in the right context. It is just not a magic mirror.
PFAS in blood makes the whole issue feel personal.
Water contamination can sound abstract. Industrial emissions can sound distant. But blood changes the tone of the conversation. It is no longer just about what is in the river or the treatment plant. It is about what has already moved through the system and into us.
That is exactly why this topic has become so politically and scientifically charged. PFAS in blood is not the beginning of exposure. It is evidence that exposure has already happened. (1)
First, some legacy PFAS levels have declined in population biomonitoring where production and use were reduced. That matters because it shows policy can work.
Second, science is getting much better. Human biomonitoring in Europe and the U.S. is giving policymakers stronger evidence and more realistic exposure assessment means fewer blind spots.
Third, treatment technologies exist. They are not perfect, and they do not all solve the same part of the problem. But the conversation has moved beyond “Is PFAS a problem?” to “How do we remove it efficiently, manage the waste responsibly, and stop new PFAS from entering the system?” That is real progress.
At instrAction, we work on the part of the PFAS story that comes before another blood test ever becomes necessary.
If PFAS in blood tells us that exposure has already happened, then the obvious next step is to reduce what reaches people in the first place. That means identifying contamination pathways, removing PFAS from water effectively, and making sure captured contaminants are handled responsibly rather than simply moved around.
The good news is that solutions are already here and this is exactly the moment to use them. From selective absorber materials to mobile treatment systems that can be deployed directly on site, there are now practical ways to act earlier and more effectively.
If PFAS is a challenge in your water system, your site, or your project planning, feel free to reach out to our team. The problem is serious, but it is not untouchable.
Because cleaner water upstream is still the most meaningful way to lower exposure downstream.
(1) https://www.atsdr.cdc.gov/
(2) https://www.epa.gov/
(3) https://www.hbm4eu.eu/wp-content/uploads/2022/07/PFAS_Substance-report.pdf?utm_
(4) https://www.eea.europa.eu/en/european-zero-pollution-dashboards/indicators/risk-of-pfas-in-humans
(5) https://www.nationalacademies.org/news/new-report-calls-for-expanded-pfas-testing-for-people-with-history-of-elevated-exposure-offers-advice-for-clinical-treatment
(6) https://www.ncbi.nlm.nih.gov/books/NBK584702/